Tower Research Capital LLC (Trc) Nuvectis Pharma, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 588 shares of NVCT stock, worth $2,998. This represents 0.0% of its overall portfolio holdings.
Number of Shares
588
Previous 5,996
90.19%
Holding current value
$2,998
Previous $37,000
91.89%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding NVCT
# of Institutions
32Shares Held
1.65MCall Options Held
0Put Options Held
0-
Ronit Capital LLP563KShares$2.87 Million5.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA301KShares$1.54 Million0.0% of portfolio
-
Baldwin Brothers LLC174KShares$888,0620.08% of portfolio
-
Black Rock Inc. New York, NY83.4KShares$425,4010.0% of portfolio
-
Geode Capital Management, LLC Boston, MA79.7KShares$406,5510.0% of portfolio
About Nuvectis Pharma, Inc.
- Ticker NVCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,642,500
- Market Cap $74.7M
- Description
- Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...